.
MergerLinks Header Logo

New Deal


Announced

Completed

Ascendis Health completed the acquisition of Scitec and Remedica for €500m.

Financials

Edit Data
Transaction Value-
Consideration TypeContingent Deferred Consideration, Cash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Sources

Edit

Tags

Edit

pharmaceuticals

Pharmaceuticals

Cyprus

Private

Completed

Friendly

Cross Border

Acquisition

Majority

Single Bidder

Synopsis

Edit

Ascendis Health, a health and wellness company, completed the acquisition of Scitec, a sports nutrition company, and Remedica, a pharmaceutical manufacturer, for €500m. “We are extremely excited to finally make this announcement, as not only will we gain access to meaningful global platforms, brands and distribution synergies, but we will also inherit a world class staff compliment of industry leading professionals with knowledge and experience that will benefit Ascendis in the long term, and ultimately create value for our clients and shareholders,” Karsten Wellner, Ascendis CEO.

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US